Filter
2384
Filtered Results: 2384
Text search:
World
Health
Organization
(South-East
Asia)
Featured
Recommendations
200
New Publications
588
Language
Document type
No document type
1243
Studies & Reports
601
Guidelines
238
Manuals
111
Strategic & Response Plan
78
Fact sheets
32
Training Material
29
Situation Updates
23
Resource Platforms
15
Infographics
9
Online Courses
3
Brochures
2
Countries / Regions
Global
171
India
96
South–East Asia Region
87
Myanmar / Burma
84
Nepal
64
Bangladesh
50
Asia
50
Indonesia
39
Philippines
38
Africa
36
Western and Central Europe
31
Cambodia
29
Ethiopia
23
South Africa
23
Kenya
22
Uganda
21
Nigeria
19
Syria
19
Middle East and North Africa
18
Thailand
16
Western Pacific Region
16
Tanzania
15
Pakistan
14
Latin America and the Carribbean
14
Liberia
13
Congo, Democratic Republic of
13
Zambia
13
West and Central Africa
13
East and Southern Africa
12
Ghana
11
Afghanistan
11
Malawi
11
Mozambique
11
Eastern Europe
11
Haiti
10
China
10
Ukraine
10
Yemen
10
Rwanda
9
Russia
9
Vietnam
9
Zimbabwe
8
South Sudan
8
Brazil
8
Sierra Leone
7
Laos
7
Senegal
6
Somalia
6
Sri Lanka
6
Eastern Europe and Central Asia
6
Cameroon
5
Sudan
5
Burkina Faso
4
Jordan
4
Malaysia
4
Central African Republic
4
Madagascar
4
Venezuela
4
Timor Leste/ East Timor
4
Moldova
4
Iran
4
Japan
4
Guinea
3
USA
3
Egypt
3
Papua New Guinea
3
Namibia
3
North Macedonia
3
Botswana
3
Albania
3
Georgia
3
Bosnia and Herzegovina
3
Mali
2
Iraq
2
Lebanon
2
Turkey
2
Eswatini/ Swaziland
2
Serbia
2
Croatia
2
Colombia
2
Mexico
2
North Korea
2
Italy
2
Tajikistan
2
Kyrgyzstan
2
Kazakhstan
2
Turkmenistan
2
Belarus
2
Morocco
1
Saudi Arabia
1
Niger
1
Singapore
1
Benin
1
Vanuatu
1
Argentina
1
Peru
1
Hungary
1
Honduras
1
Ecuador
1
Bolivia
1
Greece
1
Libya
1
Angola
1
Lesotho
1
Other region
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Poland
1
Palestine
1
Djibouti
1
Armenia
1
Mongolia
1
Canada
1
Qatar
1
Romania
1
Gabon
1
Belgium
1
Maldives
1
Tunisia
1
Portugal
1
Spain
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
583
Clinical Guidelines
260
Public Health
176
Women & Child Health
161
Key Resources
122
Capacity Building
51
Pharmacy & Technologies
29
Toolboxes
HIV
237
Mental Health
211
Planetary Health
170
COVID-19
151
TB
115
NTDs
104
AMR
95
Rapid Response
85
Disability
84
Global Health Education
76
NCDs
58
Refugee
53
Caregiver
51
Natural Hazards
40
Conflict
39
Health Financing Toolbox
39
Pharmacy
33
Zika
28
Ebola
21
Polio
16
Cholera
14
Specific Hazards
9
Typhoon
3
Social Ethics
2
Health Financing
1
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of mal...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Th...
Polymerase Chain Reaction (PCR) has significantly helped in early diagnosis and commencement of specific interventions for diseases control. It also plays a critical role in understanding the disease epidemiology and unraveling the transmission dynamics of the disease. This manual intends to p...
Birth defect has been an emerging major cause of child mortality in the region. Scarcity of the birth defects information hampers policy decisions and control measures at national level. In order to create evidence for action for birth defects prevention in the region, WHO-SEARO in collaboration wit...
Birth defect has been an emerging major cause of child mortality in the region. Scarcity of the birth defects information hampers policy decisions and control measures at national level. In order to create evidence for action for birth defects prevention in the region, WHO-SEARO in collaboration wit...
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
COVID-19 Infection Prevention and Control Sameeksha (Hindi; review) compiles recent key IPC resources on COVID from scientific journals, WHO guidelines, Ministry of Health and Family Welfare /Government of India guidelines, and trainings and IPC res...
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school drug-use-prevention programmes, the
captive audience, and the popular perception...
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia<...
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia<...
WHO guideline on preventive chemotherapy for public health control of strongyloidiasis
recommended
Human strongyloidiasis is a chronic parasitic disease caused by infection with Strongyloides stercoralis, a soil-transmitted helminth that is estimated to infect 300–600 million people worldwide. This neglected tropical disease (NTD) is endemic globally, predominately in the ...-East Asia, African and Western Pacific regions, and in South and Central America. Strongyloidiasis has a wide range of clinical presentations, including subclinical disease, symptomatic disease (often with diarrhoea, abdominal pain and urticaria) and a rare but deadly complication of hyperinfection with disseminated disease. The feared complication of disseminated strongyloidiasis can occur in the setting of immunocompromising conditions (e.g. human T-cell lymphotropic virus type 1 infection and malignancies) or immunosuppressive medications (e.g. steroids) and has an estimated case-fatality rate exceeding 60%. The standard treatment for chronic S. stercoralis infection is oral medication with ivermectin.
The World Health Organization (WHO) Global Status Report on Noncommunicable Diseases 2010 projects that noncommunicable diseases (NCDs) will be res...
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public ... services; and the provision of safe water, sanitation and hygiene. In 2015 alone nearly one billion people were treated for at least one disease and significant gains were achieved in relieving the symptoms and consequences of diseases for which effective tools are scarce; important reductions were achieved in the number of new cases of sleeping sickness, of visceral leishmaniasis in South-East Asia and also of Buruli ulcer.
The report also considers vector control strategies and discusses the importance of the draft WHO Global Vector Control Response 2017–2030.
The report also considers vector control strategies and discusses the importance of the draft WHO Global Vector Control Response 2017–2030.
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the...
Snakebites are well-known medical emergencies in many parts of the world, especially in rural areas. Agricultural workers and children are the most affected. The incidence of snakebite mortality is particularly high in ...-East Asia. Rational use of snake anti-venom can substantially reduce mortality and morbidity due to snakebites. These guidelines are a revised and updated version of Regional Guidelines for the Management of snakebites published by the WHO Regional Office in South-East Asia in 2011. These guidelines aim to promote the rational management of snakebite cases in various health facilities where trained health functionaries and quality snake antivenom are available.
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
